Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7LF9

Structure of Hyperglycosylated Human IgG1 Fc (Fc329)

Summary for 7LF9
Entry DOI10.2210/pdb7lf9/pdb
DescriptorIgG1 Fc (Fc329), 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (6 entities in total)
Functional Keywordseffector, igg, antibody, fc, signaling protein
Biological sourceHomo sapiens (Human)
Total number of polymer chains2
Total formula weight55445.05
Authors
Fields, J.K.,Sundberg, E.J. (deposition date: 2021-01-15, release date: 2021-01-27, Last modification date: 2023-10-18)
Primary citationFields, J.K.,Sundberg, E.J.
Silent Antibodies: Generation of Hyperglycosylated FCs to Ablate Effector Functions
To Be Published,
Experimental method
X-RAY DIFFRACTION (2.2 Å)
Structure validation

221716

PDB entries from 2024-06-26

PDB statisticsPDBj update infoContact PDBjnumon